Record numbers of patients are seeking treatment abroad to avoid long waiting times with the NHS.
New figures show more than half a million British patients left the UK for healthcare overseas last year, a 50 per cent jump in two years.
The NHS waiting list keeps rising and now stands at 7.41 million, despite a £25bn cash injection from Rachel Reeves.
Access to NHS care is now so difficult that experts have claimed people are putting themselves at risk of complications by seeking healthcare abroad.
Turkey, Poland, Romania, Portugal, India and Italy were the most popular destinations, with hip and knee replacements and cataract surgery among the most common procedures sought abroad, along with dentistry and cosmetic work.
Regulation of clinics abroad is mixed, while patients travelling thousands of miles for operations risk suffering ill effects from treatment after they return home.
Wes Streeting, the Health Secretary, said: “It’s appalling hundreds of thousands of taxpayers have been forced to go abroad for medical treatment they should be accessing for free on the NHS.
“We are overhauling the NHS to put an end to the grossly unfair two-tier system we inherited, where people who can’t afford to seek care privately get left behind. There’s a long way to go, but in the first year of this Government we’ve already delivered over five million extra appointments and cut waiting lists by 206,000.
“Too many people are also being lured overseas for cheap cosmetic procedures, only to come home with life-changing complications that end up costing the NHS. That’s why we’ve launched a major drive to raise awareness of the risks and crack down on dangerous medical tourism.”
Figures from the Office for National Statistics show 523,000 people left the UK to seek treatment abroad in 2024, up from 431,000 in 2023 and 348,000 in 2022.
During those years, the NHS waiting list in England rose from 6.1 million to 7.4 million.
Clinics in Turkey typically offer hip replacements for between £6,000 to £8,000 – around half the price of private operations in the UK.